2001
DOI: 10.1016/s0014-5793(01)02645-x
|View full text |Cite
|
Sign up to set email alerts
|

Splice donor site mutation in the lysosomal neuraminidase gene causing exon skipping and complete loss of enzyme activity in a sialidosis patient

Abstract: Sialidosis is a lysosomal storage disease caused by the deficiency of K K-N-acetylneuraminidase (NEU1; sialidase), the key enzyme for the intralysosomal catabolism of sialylated glycoconjugates. We have identified a homozygous transversion in the last intron (IVSE +1 G s C) in neu1 of a sialidosis patient. Sequencing of the truncated cDNA revealed an alternatively spliced neu1 transcript which lacks the complete sequence of exon 5. Skipping of exon 5 leads to a frameshift and results in a premature termination… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
5
1

Year Published

2002
2002
2017
2017

Publication Types

Select...
6
2

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(6 citation statements)
references
References 28 publications
0
5
1
Order By: Relevance
“…Additionally, no pre‐mRNA and mature mRNA of neu1 were detectable in both patients. The finding of a total lack of neu1 transcripts in our patients is in contrast to the cases so far published [4,6,9,10,12]. It was suggested that a complete absence of lysosomal neuraminidase is lethal during foetal development or at birth [9].…”
Section: Discussioncontrasting
confidence: 85%
See 1 more Smart Citation
“…Additionally, no pre‐mRNA and mature mRNA of neu1 were detectable in both patients. The finding of a total lack of neu1 transcripts in our patients is in contrast to the cases so far published [4,6,9,10,12]. It was suggested that a complete absence of lysosomal neuraminidase is lethal during foetal development or at birth [9].…”
Section: Discussioncontrasting
confidence: 85%
“…In view of the fact that even an intronic mutation can cause a complete deficiency of the lysosomal neuraminidase [12], we performed a sequencing‐based screening of genomic DNA from sialidosis patients. In two cases we identified the same 11 kb deletion that encompassed the entire coding region of neu1 .…”
Section: Introductionmentioning
confidence: 99%
“…The age of onset and severity of the clinical manifestations are correlated with NEU1 mutations (10,11) and the level of residual neuraminidase activity (10,12,13), indicating the existence of considerable genotype-phenotype correlation in this disease. To date, more than 40 mutations within the NEU1 gene have been identified in patients with sialidosis type I or type II (2,3,(10)(11)(12)(13)(14)(15)(16)(17)(18)(19)(20)(21)(22)(23)(24).…”
Section: Introductionmentioning
confidence: 99%
“…Since then, about 17 genetic confirmed patients from different ethnic groups have been reported with extensive efforts related to the molecular pathology of NEU1 gene without a detailed description of the clinical evaluation. [1,14–21]. Furthermore, comprehensive investigation with multimodality electrophysiological studies and neuroimaging might be currently overlooked.…”
Section: Introductionmentioning
confidence: 99%